O'Neill Gilmore Neil's Form 4 filing
Editas Medicine, Inc. (EDIT) · filed Mar 4, 2026
- Accession no.
- 0001650664-26-000009
- Filed
- Mar 4, 2026
- Trade date
- Mar 3, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $10.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| O'Neill Gilmore NeilCIK 0001742084 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Common Stock | SSaleDisposed | −5,394 | $2.02 | −$10,895.88 | 263,693 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.